Interestingly, a study by Wright et al. [35] using a murine mammary adenocarcinoma model demonstrated that LV administrated as a bolus injection resulted in an expanded pool of MeTHF and towards longer polyglutamate chains suggesting stronger TYMS inhibition. Here, TYMS is linked to breast adenocarcinoma.